Oxurion NV, a biopharmaceutical company, develops and commercializes medicines for the treatment of eye diseases in Belgium and internationally. Its lead product is JETREA for the treatment of vitreomacular adhesion/vitreomacular traction. The company also develops THR-149, a plasma kallikrein inhibitor, which is in Phase II clinical trials for the treatment of diabetic macular edema (DME); and THR-687, an integrin antagonist which is in Phase II clinical trials for the treatment of DME. It has collaboration agreements with Bicycle Therapeutics, INC Research, and Galapagos NV. The company was formerly known as ThromboGenics NV and changed its name to Oxurion NV in September 2018. Oxurion NV was founded in 1991 and is headquartered in Leuven, Belgium.
प्रकार | 5 मिनट | 15 मिनट | प्रति घंटा | दैनिक | मासिक |
|---|---|---|---|---|---|
| मूविंग एवरेज | खरीदें | खरीदें | खरीदें | तटस्थ | मजबूत विक्रय |
| तकनीकी संकेतक | मजबूत खरीद | मजबूत खरीद | मजबूत खरीद | मजबूत खरीद | मजबूत विक्रय |
| सारांश | मजबूत खरीद | मजबूत खरीद | मजबूत खरीद | खरीदें | मजबूत विक्रय |
नाम | अंतिम | उच्च | निम्न | बदलाव | बदलाव % | वॉल्यूम | समय | ||
|---|---|---|---|---|---|---|---|---|---|
| 526.90 | 529.30 | 523.15 | +8.80 | +1.70% | 2.51M | NSE | |||
| 1,087.20 | 1,104.95 | 1,084.50 | -17.90 | -1.62% | 606.18K | NSE | |||
| 110.25 | 111.25 | 109.65 | -0.75 | -0.68% | 1.18M | NSE | |||
| 136.70 | 138.50 | 136.35 | +1.15 | +0.85% | 12.63M | NSE | |||
| 2,654.95 | 2,657.25 | 2,644.00 | -6.35 | -0.24% | 906.57K | NSE | |||
| 1,505.35 | 1,512.00 | 1,504.55 | -6.35 | -0.42% | 589.40K | NSE | |||
| 2,490.00 | 2,498.95 | 2,480.00 | +11.30 | +0.46% | 108.26K | NSE | |||
| 825.65 | 833.30 | 821.00 | -3.35 | -0.40% | 8.87K | NSE | |||
| 771.40 | 779.55 | 769.10 | -2.55 | -0.33% | 522.02K | NSE | |||
| 166.50 | 166.95 | 163.95 | +2.55 | +1.56% | 2.00K | NSE | |||
| 436.05 | 442.00 | 435.65 | -2.00 | -0.46% | 1.48M | NSE | |||
| 304.80 | 306.95 | 303.65 | +0.50 | +0.16% | 796.00 | NSE | |||
| 482.85 | 488.10 | 482.60 | -1.95 | -0.40% | 2.40M | NSE | |||
| 2,236.60 | 2,293.10 | 2,227.05 | -34.50 | -1.52% | 72.18K | NSE | |||
| 4.05 | 4.05 | 4.05 | 0.00 | 0.00% | 0.00 | NSE |